Skip to content

Combined Brain and Peripheral Nerve Stimulation for Stroke

Combined Brain and Peripheral Nerve Stimulation to Enhance Beneficial Effects of Functional Electrical Stimulation on Hand Motor Function After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01907737
Enrollment
22
Registered
2013-07-25
Start date
2013-07-31
Completion date
2016-07-31
Last updated
2019-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Cerebrovascular disease is a major cause of disability worldwide. The catastrophic burden of stroke is more dramatic in low- and middle- income countries, and the scarcity of evidence-based rehabilitation interventions represents a major challenge to global health care. Upper limb weakness is frequent after stroke, but there is no universally accepted treatment to effectively improve hand function in patients with moderate and severe motor impairment. These are the patients in deepest need of rehabilitative interventions. This project addresses this important issue, by testing effects of a novel approach. We will non-invasively stimulate the brain and peripheral nerves in order to enhance effects of motor training aided by an electrical stimulation device in patients with moderate to severe hand weakness. Our hypothesis is that brain stimulation, when added to peripheral nerve stimulation, will enhance effects of motor training to a greater extent than brain stimulation alone, peripheral stimulation alone, or no stimulation.

Detailed description

The goal of this study is to compare the effects of FES in close association with either transcranial direct current stimulation (tDCS) alone, peripheral nerve stimulation (PNS)alone, tDCS + PNS or sham tDCS + sham PNS, in patients with moderate to severe upper limb weakness, in a cross-over design. The working hypothesis of this proof-of-principle study is that either tDCS or PNS will enhance effects of functional electrical stimulation (FES) to a greater extent than placebo tDCS and PNS, and that the combination of tDCS and PNS will further improve motor outcomes than either tDCS or PNS alone. The interventions will consist of outpatient motor training of the paretic wrist with FES in four experimental sessions separated by two weeks. In each session, either active tDCS + sham PNS, active PNS + sham tDCS,active tDCS + active PNS or sham tDCS + sham PNS will be applied. PNS will be applied for 2 hours and tDCS will be applied in the last 20 minutes before completion of PNS. The order of the sessions will be randomized across patients. Before the first session, patients will be familiarized with the FES device.

Interventions

OTHERActive tDCS

Active tDCS will be applied with the anode positioned over the ipsilesional M1 and the cathode over the contralateral supraorbital region for 20 minutes (1mA).

OTHERActive PNS

Active PNS will be administered by 2 pairs of surface electrodes (cathode proximal). One pair will overly the median and ulnar nerves at the wrist, and the other pair will overly the radial nerve. Trains of electric stimulation will be delivered at 1 Hz by using isolation units connected to a square pulse stimulator.

OTHERSham tDCS

In sham tDCS, no current will be delivered through the tDCS device.

OTHERSham PNS

No current will be delivered to the radial, ulnar and median nerves.

Sponsors

Fundação Faculdade de Medicina
CollaboratorOTHER
University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age, 18 years or older; * First-ever, ischemic or hemorrhagic stroke at least six months before, confirmed by computed tomography or magnetic resonance imaging; * Moderate to severe motor impairment of an upper limb, defined as a score between 7 and 50 on the Fugl-Meyer Assessment of Sensorimotor Recovery after stroke, a scale with scores for upper limb ranging from 0 (no function) to 66 (normal function; * Ability to provide written Informed Consent (patient or legal representative); * Ability to comply with the schedule of interventions and evaluations in the protocol.

Exclusion criteria

* Lack of ability to voluntarily activate any active range of wrist extension; * Anesthesia of the paretic hand; * Stroke lesions affecting entirely the hand knob area of the motor cortex120; * Stroke lesions affecting the cerebellum or the brain stem; * Severe spasticity at the paretic elbow, wrist, or fingers, defined as a score of \>3 on the Modified Ashworth Spasticity Scale; * Active joint deformity; * Uncontrolled medical problems such as end-stage cancer or renal disease; * Pregnancy; * Seizures; * Pacemakers; * Other neurological disorders such as Parkinson's disease; * Psychiatric illness including severe depression; * Aphasia or serious cognitive deficits that preclude comprehension of the experimental protocol or ability to provide consent. A score in the Minimental State Examination lower than 23/30 points will be used for patients with higher than 1 year of education, and a score lower than 19/30 will be used for patients with 1 year of education or less.

Design outcomes

Primary

MeasureTime frameDescription
Active Range of Motion of Wrist Extension in the Paretic SidePre- and post-intervention on each intervention dayIn this cross-over study, the primary outcome was measured immediately before and after each session of treatment. In each session, one of the four possible interventions was administered.

Countries

Brazil

Participant flow

Participants by arm

ArmCount
Four Interventions in a Cross-over Design
* 1 session of active transcranial direct current stimulation (TDCS) of the hemisphere affected by the stroke and active peripheral nerve stimulation (PNS) * 1 session of active transcranial direct current stimulation (TDCS) of the hemisphere affected by the stroke and sham peripheral nerve stimulation (PNS) * 1 session of sham transcranial direct current stimulation (TDCS) of the hemisphere affected by the stroke and active peripheral nerve stimulation (PNS) * 1 session of sham transcranial direct current stimulation (TDCS) of the hemisphere affected by the stroke and sham peripheral nerve stimulation (PNS)
20
Total20

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicFour Interventions in a Cross-over Design
Age, Continuous56.6 years
STANDARD_DEVIATION 12.3
Ethnicity (NIH/OMB)
Hispanic or Latino
20 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Region of Enrollment
Brazil
20 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 210 / 210 / 210 / 22
other
Total, other adverse events
0 / 210 / 210 / 211 / 22
serious
Total, serious adverse events
0 / 210 / 210 / 210 / 22

Outcome results

Primary

Active Range of Motion of Wrist Extension in the Paretic Side

In this cross-over study, the primary outcome was measured immediately before and after each session of treatment. In each session, one of the four possible interventions was administered.

Time frame: Pre- and post-intervention on each intervention day

Population: Of twenty two participants who started the study, one participant only participated in one of the four sessions, while the remainder participated in all four. Of the 21 participants who completed four sessions, one was removed from analyses after meeting exclusion criteria

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCS and Active PNSActive Range of Motion of Wrist Extension in the Paretic SideBefore stimulation37.8 degreesStandard Deviation 11.6
Active tDCS and Active PNSActive Range of Motion of Wrist Extension in the Paretic SideAfter stimulation36.5 degreesStandard Deviation 13.2
Active tDCS and Sham PNSActive Range of Motion of Wrist Extension in the Paretic SideAfter stimulation36.2 degreesStandard Deviation 13.7
Active tDCS and Sham PNSActive Range of Motion of Wrist Extension in the Paretic SideBefore stimulation38 degreesStandard Deviation 14.2
Sham tDCS and Active PNSActive Range of Motion of Wrist Extension in the Paretic SideBefore stimulation37.2 degreesStandard Deviation 13.9
Sham tDCS and Active PNSActive Range of Motion of Wrist Extension in the Paretic SideAfter stimulation37.4 degreesStandard Deviation 15.1
Sham tDCS and Sham PNSActive Range of Motion of Wrist Extension in the Paretic SideBefore stimulation38 degreesStandard Deviation 14.2
Sham tDCS and Sham PNSActive Range of Motion of Wrist Extension in the Paretic SideAfter stimulation36.2 degreesStandard Deviation 13.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026